Use of Intravenous Immunoglobulin and Intravenous Methylprednisolone in Hyperhaemolysis Syndrome in Sickle Cell Disease

By Win Nay   Yeghen Tullie   Needs Malcolm   Chen Frederick E.   Okpala Iheanyi  

Hematology, Vol. 9, Iss. 5-6, 2004-10 ,pp. : 433-436

Maney Publishing

Access to resources Recommend Favorite

Major surgery in a neutropenic patient undergoing allogeneic stem cell transplantation for high risk myelofibrosis

By Brodin Petter  

International Journal of Hematology, Vol. 96, Iss. 6, 2012-12 ,pp. : 798-800

Springer Publishing Company

Access to resources Recommend Favorite

Myelofibrosis with myeloid metaplasia in a patient with relapsed Hodgkin's lymphoma who underwent autologous hematopoietic stem cell transplantation

By Massa Federico Sackmann   Rolón Juliana Martinez   Pavlovsky Santiago  

Hematology, Vol. 12, Iss. 6, 2007-12 ,pp. : 487-488

Maney Publishing

Access to resources Recommend Favorite

Wilms tumor gene peptide-based immunotherapy for patients with overt Leukemia from myelodysplastic syndrome (MDS) or MDS with myelofibrosis

By Oka Yoshihiro   Tsuboi Akihiro   Murakami Masaki   Hirai Manabu   Tominaga Nobuhiko   Nakajima Hiroko   Elisseeva Olga   Masuda Tomoki   Nakano Akiko   Kawakami Manabu   Oji Yusuke   Ikegame Kazuhiro   Hosen Naoki   Udaka Keiko   Yasukawa Masaki   Ogawa Hiroyasu   Kawase Ichiro   Sugiyama Haruo  

International Journal of Hematology, Vol. 78, Iss. 1, 2003-02 ,pp. : 56-61

Springer Publishing Company

Access to resources Recommend Favorite

Management of hyperhaemolysis after a transfusion in sickle‐cell patients

By  

ISBT SCIENCE SERIES, Vol. 11, Iss. S1, 2016-01 ,pp. : 196-200

John Wiley & Sons Inc

Access to resources Recommend Favorite